A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction
about
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsTargeting the chromosome partitioning protein ParA in tuberculosis drug discoveryThe anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies.Emerging drug therapies for benign prostatic hyperplasia.Lower urinary tract symptoms in men.Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation.Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importancePhenoxybenzamine is neuroprotective in a rat model of severe traumatic brain injury.Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia.Non-Hormonal treatment of BPH/BOOBenign prostatic hyperplasia: the best treatment.Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic HyperplasiaMedical therapy for benign prostatic hyperplasia: the road ahead.New Treatments for Benign Prostatic Hyperplasia: Prostatectomy and other forms of therapy.Effectiveness of 'on demand' silodosin in the treatment of premature ejaculation in patients dissatisfied with dapoxetine: a randomized control study.The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate.Electrical and mechanical properties of the capsular smooth muscles of the rabbit prostate in relation to the actions of the alpha 1-adrenoceptor blocker, YM-12617.Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.Medical treatment for benign prostatic hyperplasia.Controlled-release doxazosin in the treatment of benign prostatic hyperplasia.Alteration of loperamide-induced prostate relaxation in high-fat diet-fed rats
P2860
Q28343383-7CDC8F38-8240-4D6F-9623-0DB107319B77Q28486773-7C203480-3E26-40EE-96B5-90393F3E13C4Q30614521-64BB2C98-AD0A-4351-9688-34DAD60F4F80Q34119559-E1E643E5-CAF9-422E-B627-4FEE04C97EF3Q34190626-9CB65A6B-3A69-4A61-84C5-37268CB54220Q34565171-CA41ECC1-86A2-4786-8AD4-E4E95582DFFAQ35225398-5D700448-0B62-4334-A795-23D593D71FCFQ35872541-3CD6FB18-2139-4A77-9A33-5CB37A1978AEQ35919193-0B62430A-56ED-4B66-BE8E-053ED5573947Q36501500-04003C03-233F-40A4-9189-A0EDA457304EQ37111860-1AB16862-C35F-49E0-87C8-67CD6F7D49C0Q37365172-A4E4D45A-7E54-460C-B882-1B45C71CF0F8Q37432103-6B68CF54-08B2-4443-84C3-B18389F08BB4Q37535647-D050246A-B32D-4909-8352-AB9D9DEB8C65Q38105608-782C7E3B-66C0-444F-840A-FA7C0F91FA21Q38205423-221188AD-DEDC-4C2F-9BD6-E54748F1F1EBQ38206081-352FB92D-2FCE-4EAD-A87C-010AB572B932Q38468579-D18C6450-4E76-42F8-A03B-BC4800AE536DQ40902682-38C76452-535A-402D-B82E-D4431826EB44Q41154152-0BBCF531-E7EC-4BD3-A6A2-3599B1843BCAQ41388555-E03EF53F-30DE-46AD-B514-9D302D45AAE9Q41951939-08CCD9BB-F0A9-4D73-ABEA-0E78E46C919FQ42122652-6D920435-3F9A-433C-9387-03452A83393EQ42128261-D4BE7C77-B011-4F84-960A-3DC8483E1BCEQ42765384-96ACB1A9-EA7B-43F8-B33A-F657395F2AD8Q46786976-86132C8A-88BA-4FA7-A8BE-B406FB9BF3E6Q59100446-1F187955-C684-4C33-B24A-A7D171A898AF
P2860
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction
description
1978 nî lūn-bûn
@nan
1978 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
A placebo-controlled double-bl ...... n benign prostatic obstruction
@ast
A placebo-controlled double-bl ...... n benign prostatic obstruction
@en
A placebo-controlled double-bl ...... n benign prostatic obstruction
@nl
type
label
A placebo-controlled double-bl ...... n benign prostatic obstruction
@ast
A placebo-controlled double-bl ...... n benign prostatic obstruction
@en
A placebo-controlled double-bl ...... n benign prostatic obstruction
@nl
prefLabel
A placebo-controlled double-bl ...... n benign prostatic obstruction
@ast
A placebo-controlled double-bl ...... n benign prostatic obstruction
@en
A placebo-controlled double-bl ...... n benign prostatic obstruction
@nl
P2093
P3181
P1476
A placebo-controlled double-bl ...... n benign prostatic obstruction
@en
P2093
P3181
P356
10.1111/J.1464-410X.1978.TB06210.X
P407
P577
1978-12-01T00:00:00Z